10x Genomics (TXG) Shares Issued (2018 - 2025)
Historic Shares Issued for 10x Genomics (TXG) over the last 8 years, with Q4 2025 value amounting to $2.2 million.
- 10x Genomics' Shares Issued fell 5036.53% to $2.2 million in Q4 2025 from the same period last year, while for Dec 2025 it was $6.8 million, marking a year-over-year decrease of 3766.72%. This contributed to the annual value of $6.8 million for FY2025, which is 3766.72% down from last year.
- 10x Genomics' Shares Issued amounted to $2.2 million in Q4 2025, which was down 5036.53% from $617000.0 recorded in Q3 2025.
- In the past 5 years, 10x Genomics' Shares Issued ranged from a high of $16.2 million in Q2 2021 and a low of $156000.0 during Q3 2024
- Its 5-year average for Shares Issued is $4.9 million, with a median of $4.6 million in 2024.
- Over the last 5 years, 10x Genomics' Shares Issued had its largest YoY gain of 124141.03% in 2021, and its largest YoY loss of 9858.32% in 2021.
- Quarter analysis of 5 years shows 10x Genomics' Shares Issued stood at $8.9 million in 2021, then crashed by 43.83% to $5.0 million in 2022, then rose by 12.24% to $5.6 million in 2023, then fell by 19.53% to $4.5 million in 2024, then tumbled by 50.37% to $2.2 million in 2025.
- Its last three reported values are $2.2 million in Q4 2025, $617000.0 for Q3 2025, and $3.5 million during Q2 2025.